MNDL Bio
Synthetic biology company aiming to reduce cost and production time of food and biotech applications through computational tools that optimize gene expression.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor | €0.0 | round | |
* | $2.0m | Seed | |
| Total Funding | 000k | ||
Related Content
MNDL Bio is a cutting-edge Synthetic Biology startup focused on revolutionizing the Food and Biotech industries. The company leverages advanced computational tools to optimize gene expression, which is the process by which information from a gene is used to create a functional product like a protein. By enhancing this process, MNDL Bio aims to significantly reduce both the cost and production time of various applications in these sectors.
The company operates in the synthetic biology market, which involves redesigning organisms for useful purposes by engineering them to have new abilities. This market is rapidly growing, driven by the increasing demand for sustainable and efficient production methods in food and biotechnology.
MNDL Bio primarily serves clients in the food production and biotech industries. These clients are looking for innovative ways to improve their production processes, reduce costs, and increase efficiency. The company’s technology is based on over 15 years of academic research from the Tuller's Lab and utilizes artificial intelligence (AI) and machine learning (ML) to analyze genomic big data. This allows MNDL Bio to create proprietary solutions tailored to the specific needs of different hosts and target genes.
The business model of MNDL Bio involves offering its proprietary computational platforms as a service to its clients. These platforms help clients optimize their gene expression processes, leading to faster and more cost-effective production. The company generates revenue by charging for access to its technology and expertise, as well as through partnerships and collaborations with other organizations in the food and biotech sectors.
MNDL Bio has already gained recognition in the industry, having won the 7th COLLER STARTUP COMPETITION. The founding team includes experienced professionals like Steve Grun (CEO), Prof. Tamir Tuller (CSO), and Eran Miller (CBO), who bring a wealth of knowledge and expertise to the company.
Keywords: Synthetic Biology, Gene Expression, Computational Tools, Food Industry, Biotech Applications, AI, ML, Cost Reduction, Production Efficiency, Genomic Data.